Alexander Pantelyat, M.D.

Associated Investigator
E-mail: [email protected]

Dr. Pantelyat is an Associate Professor in the Department of Neurology. His research is primarily focused on patients with atypical movement disorders and cognitive decline, including the development of biomarkers and clinical assessment tools to improve diagnosis and track response to treatment.

Publications

• Young C, Cholerton B, Smith A, Shahid-Besanti M, Abdelnour C, Mormino E, Hu S-C, Chung K, Peterson A, Rosenthal L, Pantelyat A, Dawson T, Quinn J, Zabetian C. Montine T, Poston K. The Parkinson’s Disease composite of executive functioning: A measure for detecting cognitive decline in clinical trials. Neurology, 2024; 103L e209609.
• VanderVrede L, LaJoie R, Thihssen E, Asken B, Vento S, Tsuei T, Baker S, Cobigo Y, Fonseca C, Heuer H, Kramer J, Ljubenkov P, Rabinovici G, Rojas J, Rosen H, Staffaroni A, Boeve B, Dickerson B, Grossman M, Huey E, Irwin D, Litvan I, Pantelyat A, Tartaglia M, Dage J, Boxer A. Evaluation of plasma phosphorylated tau217 for differentiation between Alzheimer’s disease and frontotemporal lobar degeneration subtypes among patients with corticobasal syndrome. JAMA Neurol, 2023, 80: 495-505.
• Wills A-M, Pantelyat A, Espay A, Chan J, Litvan I, Xie T, Dale M, Gunzler S, Tartaglia M, Fox S, Rodriguez-Porcel F, Sharma M, Lang A, Boxer A, Golbe L. A modified progressive supranuclear palsy rating scale for virtual assessments. Mov Disord, 2022; 37: 1265-1271.